VITROCELL will participate in the 22nd International Congress of the European Society of Toxicology In Vitro (ESTIV 2024). It is set to convene in the historic and picturesque city of Prague from June 3-6, 2024. Centered around the pivotal theme, ‘The Application of NAMs in Drug Discovery and Drug and Chemical Safety Assessment,’ the congress promises to be a comprehensive platform for professionals to showcase and discuss the latest advancements and research in the field.
The congress will commence with a pre-congress workshop titled ‘How to write and manage a successful EU Horizon proposal: From initial idea to execution.‘ This session, organized in collaboration with the EU H2020 granted project ONTOX, aims to provide invaluable insights and guidance on navigating the complexities of EU Horizon proposals.
For more detailed information please visit the following page:
ESTIV 2024 – 22st International Congress of the European Society of Toxicology In Vitro
